| Target Price | $62.73 |
| Price | $75.96 |
| Deviation |
17.42%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Lemonade 2027 .
The average Lemonade target price is $62.73.
This is
17.42%
register free of charge
$89.25
17.50%
register free of charge
$33.33
56.12%
register free of charge
|
|
| A rating was issued by 16 analysts: 3 Analysts recommend Lemonade to buy, 6 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Lemonade stock has an average upside potential 2027 of
17.42%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 526.50 | 737.81 |
| 22.50% | 40.13% | |
| EBITDA Margin | -36.70% | -18.22% |
| 28.18% | 50.35% | |
| Net Margin | -38.40% | -24.59% |
| 30.32% | 35.97% |
13 Analysts have issued a sales forecast Lemonade 2025 . The average Lemonade sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Lemonade EBITDA forecast 2025. The average Lemonade EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Lemonade Analysts have issued a net profit forecast 2025. The average Lemonade net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.85 | -2.43 |
| 16.18% | 14.74% | |
| P/E | negative | |
| EV/Sales | 7.41 |
14 Analysts have issued a Lemonade forecast for earnings per share. The average Lemonade EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Nov 25 2025 |
| Citizens |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 17 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 10 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Nov 25 2025 |
|
Locked
Citizens:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 17 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 10 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 07 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Sep 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


